Literature DB >> 3942901

Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area.

A Y Deutch, M Goldstein, R H Roth.   

Abstract

The effects of selective stimulation of perikarya, but not axons of passage, within the ventral tegmental area (VTA) on the locus coeruleus (LC) noradrenergic system were examined. Anterograde and combined retrograde-immunohistochemical studies indicated both dopaminergic and non-dopaminergic projections to the region of the LC originating from the VTA. Kainic acid (KA) stimulation of the VTA resulted in a dose-dependent increase in the levels of the dopamine metabolite dihydroxyphenylacetic acid (DOPAC) in the prefrontal cortex, and also elevated levels of the norepinephrine (NE) metabolite 3-methoxy-4-hydroxyphenolglycol (MHPG). Prefrontal cortical MHPG levels did not increase in response to vehicle injection or KA infusion into the hippocampus, nor did concentrations of this metabolite increase in the prefrontal cortex in response to intra-VTA KA in animals with neurotoxic lesions of the VTA. KA injection into the VTA resulted in increased MHPG levels in the hippocampus, but not the hypothalamus. Dorsal noradrenergic bundle knife cuts prevented the KA-elicited prefrontal cortical MHPG increase. These data suggest that stimulation of the mesocoeruleo dopaminergic projection arising from the VTA results in selective excitation of the LC-derived dorsal bundle noradrenergic system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942901     DOI: 10.1016/0006-8993(86)91016-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

2.  Synaptic inhibition in the rat hippocampus in vivo following stimulation of the substantia nigra and ventral tegmentum.

Authors:  P M Spencer; H V Wheal
Journal:  J Physiol       Date:  1990-04       Impact factor: 5.182

Review 3.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

4.  Anatomical and pharmacological characterization of catecholamine transients in the medial prefrontal cortex evoked by ventral tegmental area stimulation.

Authors:  Tatiana A Shnitko; Donita L Robinson
Journal:  Synapse       Date:  2013-11-28       Impact factor: 2.562

5.  Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res       Date:  2009-07-24       Impact factor: 3.252

6.  Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation.

Authors:  Yan Lin; David Quartermain; Adrian J Dunn; David Weinshenker; Eric A Stone
Journal:  Synapse       Date:  2008-07       Impact factor: 2.562

Review 7.  What birdsong can teach us about the central noradrenergic system.

Authors:  Christina B Castelino; Marc F Schmidt
Journal:  J Chem Neuroanat       Date:  2009-08-15       Impact factor: 3.052

Review 8.  Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.

Authors:  David Weinshenker; Philip V Holmes
Journal:  Brain Res       Date:  2015-11-20       Impact factor: 3.252

9.  The effects of locus coeruleus and norepinephrine in methamphetamine toxicity.

Authors:  Michela Ferrucci; Filippo S Giorgi; Alessia Bartalucci; Carla L Busceti; Francesco Fornai
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.